| Home page > Company profile |
The history of our parent Company, Terumo Corporation, spans an even greater period in medical device development. In the early 1920's, a group of Japanese doctors responded to the shortage of medical equipment in Japan by forming a company to develop a superior clinical thermometer for domestic distribution. That company later became Terumo Corporation. It has continued to grow and is now one of the largest suppliers of medical devices in Japan.
1921 Foundation of the Company
1922 Introduction
of the first clinical themometer
1964 Launch
of disposable hypodermic syringes
1969 Production
and launch of blood bags
1971 Terumo
America is founded in the USA, Terumo Europe is founded in Belgium
1981 Introduction
of the first hollow fiber oxygenator
1985 Introduction
of Terumo Hydrophilic Guidewire
1986 Commercialisation
of Terumo PTCA Catheter
1999 Terumo
aquires the Sarns and CDI brands from 3M and founded Terumo Cardiovascular
Systems (USA)
2000 Launch
of Tsunami, Tsunami, TerumoCoronary Stent
2001 Terumo
Cardiovascular Systems aquires the Lifestream International Inc, Cannulae
Division
2002 Acquisition
of Vascutek Ltd, a global leader in artificialvascular grafts
2002
Introduction of Capiox®Baby RX™ Neonatal Oxygenator and of Terumo
Advanced Perfusion System 1 in Europe.
2003 Launch
of Venosafe produced by Terumo Europe
2003
Global Distribution agreement with Biocompatibles for BeadBlock (Embolosation)
2003 Terumo forms a wholly owned subsidiary, Terumo Heart
Inc, to develop an implantable left ventricular assist device (Duraheart)
2003 Licensing Agreement with Biosensors for development
of a Drug Eluting Stent
2005
Nobori 1, clinical program for NOBORI™ DRUG-ELUTING
STENT
2005
Terumo Corporation plans to launch a syringe for insulin patients featuring
the world's smallest needle
2006 Terumo
Europe N.V. opens Representative Office in Moscow
2008 Terumo receives CE Certificate for NOBORI™ DRUG-ELUTING STENT
2008 Terumo Announces First CE Certified NOBORI™ DES in Use
2008 Terumo Opens Office in Switzerland
| Terumo Europe N.V. | |
| Founded | 1971 |
| President & CEO | Shogo Ninomiya |
| Sales |
€ 350 million (FY 08) |
| Employees | 1100 |
| Operations |
Manufacture, import, export, marketing and sales of medical products and devices |
| Products |
Over 6000 products including perfusion circuits, pumping systems, monitoring devices, cannulae & catheters for cardiovascular surgery, guidewires, catheters for interventional procedures, stents, drug eluting stents, PTA and PTCA balloons, syringes, hypodermic needles, IV catheters, blood collection systems, blood bags, sterile connecting and processing systems, diabetes care products |
| Headquarters |
Researchpark Zone 2 Haasrode Interleuvenlaan 40 / B-3001 Leuven, Belgium |
| Manufacturing |
Haasrode Plant: 40 000 square meters Daily production: 1.5 million syringes, 5.2 million needles, 1 million blood tubes, 750 000 needles for blood tubes UK Plant: 700 square meters, production of tubing packs for cardiovascular surgery |
| Investment |
Terumo Europe N.V. stock is not publicly traded in Europe. However, Terumo Corporation, the parent Company of TE, is publicly traded on the Tokyo Stock Exchange. On April 24, 2000, Terumo Corporation became one of 225 companies to form the Nikkei Average on the Tokyo Stock Exchange. |
Terumo Europe manufactures, imports, exports, markets and sells a wide range of quality products for angiography, cardiology and cardiovascular systems, transfusion, clinical test systems, patient monitoring and diabetes care which comply with the highest standards in the medical world and constantly contribute to the healthcare of people in Europe.
Terumo Europe N.V. was founded in 1971 and generates €350 million in annual sales (FY 08). While some products and devices sold by the company are produced in Japan and in the United States, select items are manufactured by Terumo Europe N.V. in Belgium (e.g. syringes, needles, vacuum tubes, catheters and introducers for interventional radiology) and in the United Kingdom (tubing packs for open heart surgery).Terumo’s state-of-the-art manufacturing facilities in Haasrode, Belgium make extensive use of automated processes and systems. Their Quality System is certified to ISO 13485 and ISO 9001 standards. Terumo’s superior manufacturing processes are a vivid example of the success that can be attained when people focus on quality. We apply the strictest standards of quality and control to every item we manufacture.
Rightly, the healthcare community demands products they can depend upon to deliver the expected benefit, time after time, with no variance. Terumo delivers this performance – dependably, predictably, and consistently.
